We are incredibly proud that Bionics Institute researchers were included in the 2024 Best Neuroscience Scientists in the World by Research.com.
Congratulations to:
- Professor Kate Hoy – Head of Cognitive Therapeutics
- Associate Professor Andrew Wise – Lead, Hearing Therapeutics
- Professor Malcolm Horne – Professor in Residence
- Professor Dexter Irvine – Honorary Research Fellow
- Professor Mark Cook – Clinical Collaborator
Professor Kate Hoy, has developed a treatment program with the aim of improving brain function for people with Alzheimer’s disease.
She has led a number of world-first brain stimulation clinical trials, including trials for the treatment and prevention of dementia.
Prof Hoy’s depth and breadth of experience in the field of non-invasive brain stimulation is largely unparalleled, having worked with a variety of stimulation methods, diverse patient populations, and a wide range of research methodologies.
“My team and I work hard to develop new treatments for people with serious cognitive disorders, such as Alzheimer’s diseases, and it’s great to receive this recognition.” Professor Kate Hoy
Associate Professor Andrew Wise is working on a world-first drug treatment which aims to restore hearing loss using nanotechnology.
The nanoparticle technology to delivers growth factors to protect the inner ear sensory cells from degeneration and promote repair following hearing loss.
His current research aims to progress this novel therapeutic approach to a first in human clinical trial that will enable the clinical translation of this exciting technology.
“Our work is aiming to develop new treatments for hearing loss to improve the lives of many people around the world with significant hearing impairment.” A/ Prof Andrew Wise
